DCGI allows PNB Vesper Life Science to conduct phase-III clinical trials on PNB 001/GPP-BALACOVIN to…
PNB 001/GPP-BALACOVIN proving to be a major breakthrough in COVID-19 treatment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
PNB Vesper Life Science
PNB Vesper to commence phase II clinical trial of COVID-19 drug in BJ Medical College, Pune
The company has already patented the molecule and secured intellectual property rights in the US, Europe and rest of the world